| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/11/2003 | US6518265 1H-imidazopyridine derivatives |
| 02/11/2003 | US6518263 Imidazo[4,5-b]pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 02/11/2003 | US6518222 N-([1,2,4] triazoloazinyl) thiophenesulfonamide compounds and their use as herbicides |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2092305C Compounds having antihypertensive and anti-ischemic properties |
| 02/11/2003 | CA2071375C Heterocyclic derivatives |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2392580A1 A process for the preparation of high purity pemirolast |
| 02/06/2003 | WO2003010511A2 Low resolution surface enhanced raman spectroscopy on sol-gel substrates |
| 02/06/2003 | WO2003010168A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 02/06/2003 | WO2003010167A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | WO2003010147A1 Acidic quinolone derivatives |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003010138A2 Piperidine derivatives as antibacterial agents |
| 02/06/2003 | WO2003009852A1 Tyrosine kinase inhibitors |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2002096423A3 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002059123A3 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002046194A3 Substituted imidazopyridines |
| 02/06/2003 | WO2002041843A3 Antiinflammation agents |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer |
| 02/06/2003 | US20030027834 Modulating a pharmacological response from the ORL1 receptor for treating chronic pain |
| 02/06/2003 | US20030027823 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | US20030027801 Administering substitued guanidine compounds for therapy of decreased blood flow or nutrient supply to retinal tissue or optic nerve, or retinal ischemia or trauma, or optic nerve injury |
| 02/06/2003 | US20030027357 ECL labels having improved non-specific binding properties, methods of using and kits containing the same |
| 02/06/2003 | US20030026745 Reaction device for organic synthesis |
| 02/06/2003 | CA2453919A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1280804A1 A process for the preparation of anti-pschotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1280530A1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 02/05/2003 | CN1395578A Byrido [2,3-d] pyrimidine-2, 7-diamine kinase inhibitors |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395487A The use of mirtazapine for treatment of sleep disorders |
| 02/05/2003 | CN1395486A Drug combination for treatment of depression and related disorders comprising mirtazapine and gepirone |
| 02/05/2003 | CN1394860A 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it |
| 02/05/2003 | CN1394859A Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1100778C Pyrrolopyriidines and processes for preapring thereof |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515023 Thrombin receptor antagonists |
| 02/04/2003 | US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/04/2003 | US6514989 Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514984 Human non-pancreatic secretory phospholipase A2 inhibitors |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514982 CRF receptor antagonists and methods relating thereto |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity |
| 02/04/2003 | US6514969 β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | CA2290766C Method of treating nitrate-induced tolerance |
| 02/04/2003 | CA2076493C Modified gamma-quinacridone pigment |
| 01/30/2003 | WO2003008414A1 Chemical compounds |
| 01/30/2003 | WO2003008413A1 Imidazopyridinones as p38 map kinase inhibitors |
| 01/30/2003 | WO2003008412A2 Hetero-bicyclic crf antagonists |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | WO2003007949A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 01/30/2003 | WO2003007945A1 Viral polymerase inhibitors |
| 01/30/2003 | WO2003007942A1 Substituted isoindoles and the use thereof |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | WO2002059129A3 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
| 01/30/2003 | WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors |
| 01/30/2003 | WO2002000617A3 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | US20030023085 For therapy and prophylaxis of condition or disorder mediated by a G-protein coupled receptor such as eating disorders, obesity, anxiety disorders and mood disorders |
| 01/30/2003 | US20030023050 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 01/30/2003 | US20030022917 Process for the manufacture of tropenol |
| 01/30/2003 | US20030022916 Anticoagulants |
| 01/30/2003 | US20030022915 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder, specific social phobia, premenstrual dysphoric disorder, and other psychological disorders |
| 01/30/2003 | US20030022914 Nitric oxide synthase inhibitors |
| 01/30/2003 | US20030022913 Novel immunomodulating compounds |
| 01/30/2003 | US20030022912 Rapid-onset medicament for treatment of sexual dysfunction |
| 01/30/2003 | US20030022898 Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) |
| 01/30/2003 | US20030022888 Use of mirtazapine for the treatment of sleep disorders |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022883 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 01/30/2003 | US20030021755 Headache therapy |
| 01/30/2003 | US20030021754 Aerosols; vaporization, cooling |
| 01/30/2003 | US20030021753 Delivery of antiemetics through an inhalation route |
| 01/30/2003 | CA2453860A1 Imidazopyridinones as p38 map kinase inhibitors |
| 01/30/2003 | CA2453650A1 Substituted isoindoles and the use thereof |
| 01/30/2003 | CA2452009A1 Chemical compounds |
| 01/30/2003 | CA2451530A1 Chemical compounds |
| 01/29/2003 | EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 01/29/2003 | EP1279519A2 Image forming material and ammonium compound |
| 01/29/2003 | EP1278749A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |